Sustainable Insight Capital Management LLC Has $7.08 Million Stake in Humana Inc. (NYSE:HUM)

Key Points

• Sustainable Insight Capital Management LLC increased its stake in Humana Inc. by 9.9%, bringing its holdings to 26,742 shares valued at approximately $7.08 million.
• Analysts have adjusted their price targets for Humana, with ratings ranging from a "hold" at $260.00 to a "buy" at $348.00, resulting in an average target of $281.62.
• Humana's latest financial results showed a net margin of 1.28% and $6.27 earnings per share, which missed estimates but reported 9.6% revenue growth year-over-year.

Sustainable Insight Capital Management LLC increased its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 9.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 26,742 shares of the insurance provider's stock after acquiring an additional 2,400 shares during the quarter. Humana comprises 3.5% of Sustainable Insight Capital Management LLC's investment portfolio, making the stock its 12th biggest position. Sustainable Insight Capital Management LLC's holdings in Humana were worth $7,076,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of HUM. Cary Street Partners Investment Advisory LLC raised its stake in shares of Humana by 63.9% in the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock valued at $31,000 after acquiring an additional 46 shares during the period. Riverview Trust Co purchased a new stake in shares of Humana in the 1st quarter valued at approximately $34,000. Garde Capital Inc. purchased a new stake in shares of Humana in the 1st quarter valued at approximately $36,000. Zions Bancorporation National Association UT purchased a new stake in shares of Humana in the 1st quarter valued at approximately $37,000. Finally, Transce3nd LLC purchased a new stake in shares of Humana in the 4th quarter valued at approximately $38,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of research analyst reports. Morgan Stanley reduced their price target on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a research note on Thursday, July 31st. Robert W. Baird reduced their price target on shares of Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a research note on Friday, July 25th. Bank of America reduced their price target on shares of Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a research note on Tuesday, June 17th. Barclays set a $275.00 target price on shares of Humana and gave the stock an "equal weight" rating in a research note on Thursday, July 31st. Finally, Truist Financial cut their target price on shares of Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a research note on Wednesday, July 16th. Eighteen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $281.45.

Humana Trading Up 1.9%

NYSE HUM traded up $5.39 on Friday, hitting $286.73. 1,729,806 shares of the company were exchanged, compared to its average volume of 1,734,631. The company's 50 day moving average price is $241.58 and its 200-day moving average price is $253.94. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The firm has a market capitalization of $34.49 billion, a P/E ratio of 22.01, a price-to-earnings-growth ratio of 1.66 and a beta of 0.44. Humana Inc. has a twelve month low of $206.87 and a twelve month high of $382.72.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%. Humana's quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.96 EPS. Analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.